4,093
Participants
Start Date
August 14, 2020
Primary Completion Date
August 30, 2021
Study Completion Date
August 30, 2021
Icosapent ethyl (IPE)
"Participants in this arm will receive study medication IPE with the following dosage schedule:~8 g of IPE (4 capsules every 12 hours - morning and evening, with food) for the first three days followed by 4 g of IPE (2 capsules every 12 hours - morning and evening, with food) thereafter (days 4-28 for treatment arm and 4-60 for prevention arm)"
Placebo
Participants in this arm will receive placebo with the following dosage schedule: 8 g of placebo (4 capsules every 12 hours - morning and evening, with food) for the first three days followed by 4 g of placebo (2 capsules every 12 hours - morning and evening, with food) thereafter (days 4-28 for treatment arm and 4-60 for prevention arm)
Instituto de Investigaciones Clínicas - Rosario, Rosario
Collaborators (1)
Amarin Pharma Inc.
INDUSTRY
Estudios Clínicos Latino América
OTHER